DZ270A1 - Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. - Google Patents

Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.

Info

Publication number
DZ270A1
DZ270A1 DZ816110A DZ816110A DZ270A1 DZ 270 A1 DZ270 A1 DZ 270A1 DZ 816110 A DZ816110 A DZ 816110A DZ 816110 A DZ816110 A DZ 816110A DZ 270 A1 DZ270 A1 DZ 270A1
Authority
DZ
Algeria
Prior art keywords
active principle
coating
new
principle
amentous
Prior art date
Application number
DZ816110A
Other languages
English (en)
French (fr)
Inventor
Jasques Ser
Jean Claude Rineau
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DZ270A1 publication Critical patent/DZ270A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ816110A 1980-02-26 1981-02-25 Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. DZ270A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8004199A FR2476485A1 (fr) 1980-02-26 1980-02-26 Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant

Publications (1)

Publication Number Publication Date
DZ270A1 true DZ270A1 (fr) 2004-09-13

Family

ID=9238982

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ816110A DZ270A1 (fr) 1980-02-26 1981-02-25 Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.

Country Status (9)

Country Link
EP (1) EP0036345B1 (sl)
JP (1) JPS56133214A (sl)
AT (1) ATE4957T1 (sl)
CA (1) CA1163923A (sl)
DE (1) DE3161148D1 (sl)
DZ (1) DZ270A1 (sl)
FR (1) FR2476485A1 (sl)
MA (1) MA19084A1 (sl)
OA (1) OA06747A (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912146A (en) * 1985-01-30 1990-03-27 Warner-Lambert Company Coated dosage forms
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
DE4328069A1 (de) * 1993-08-20 1995-02-23 Henning Berlin Gmbh Mikropartikel, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
ITPD20070274A1 (it) * 2007-08-08 2009-02-09 Sanypet S P A Crocchetta per animali e metodo per la sua produzione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010110A1 (de) * 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrokapseln mit Hilfe von synthetischen Koazervaten
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
LU72439A1 (sl) * 1975-05-09 1977-02-09
JPS5394274A (en) * 1977-01-29 1978-08-18 Ricoh Co Ltd Micro-encapsulating method

Also Published As

Publication number Publication date
EP0036345B1 (fr) 1983-10-12
CA1163923A (fr) 1984-03-20
OA06747A (fr) 1982-06-30
FR2476485B1 (sl) 1983-03-04
EP0036345A1 (fr) 1981-09-23
FR2476485A1 (fr) 1981-08-28
DE3161148D1 (en) 1983-11-17
JPH0530805B2 (sl) 1993-05-11
MA19084A1 (fr) 1981-10-01
JPS56133214A (en) 1981-10-19
ATE4957T1 (de) 1983-10-15

Similar Documents

Publication Publication Date Title
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
FR2331375A1 (fr) Procede pour l'obtention de preparations avec liberation reglee d'un principe actif
AU527784B2 (en) Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
EP0068450A3 (en) Pharmaceutical forms for oral administration
FR2387980A1 (fr) Nouveaux 2-(2,2-diarylalkyl)-1-azabicyclo (2.2.2) octanes, utiles notamment comme antidiarrheiques, et leur procede de preparation
DZ270A1 (fr) Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.
DE3462852D1 (en) Medicament preparation for external use comprising adenosin for the treatment of herpes
FR2429787A1 (fr) Nouveaux derives de l'acide thiazol-2-oxamique substitues en position 4, leur preparation et leur utilisation en tant que medicaments
JPS5781411A (en) Medicinal composition having antiviral action
OA06201A (fr) Procédé de préparation de nouveaux composés d'urée et amido .
DK0380950T3 (da) Fremgangsmåde til fremstilling af et bismuthbaseret præparat samt det aktive produkt i præparat
FR2532647B1 (fr) Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
FR2441617A1 (fr) Nouveaux derives de s-triazine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2522266B1 (fr) Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
FR2510577B1 (fr) Composes organiques azotes extraits de plantes et leurs derives, leur preparation et leurs utilisations therapeutiques, notamment en tant qu'agents antineoplastiques
FR2355839A1 (fr) Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant
ZA803765B (en) Process for the preparation of an agent which contains organic, cyclic compounds with keto and/or hydroxyl groups and surface active agents, and processes for the production of pulp using this agent
ES531260A0 (es) Procedimiento de preparar agentes farmaceuticos bactericidas utilizables contra la rinitis atrofica.
PT64821B (fr) Procede pour la preparation d'esteres pirimidin(2)iliques de l'acide thionophosphorique a effet insecticide et acaricide.
FR2460111B2 (fr) Composition a base d'un melange aqueux de n-methyl-2-pyrrolidone et d'acide 2-halogenethylphosphonique et son application au traitement de plantes
FR2430949A1 (fr) Nouvelles 4h-s-triazolo (3,4c) thieno (2,3e) 1,4-diazepines, procedes pour leur preparation et medicaments les renfermant
BG34763A3 (en) Method for preparing vindezinic sulphate
OA05817A (fr) Nouveaux dérivés de l'acide 1-aziridino-carboxylique et procédés pour leur préparation.